Efficacy and Safety of Tacrolimus as Treatment for Bleeding Caused by Hereditary Hemorrhagic Telangiectasia: An Open-Label, Pilot Study

Tacrolimus trough levels in kidney transplant recipients

(2021) Young Hui Hwang et al.   BMC Nephrology

Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hereditary Hemorrhagic Telangiectasia: A Double-Blind, Randomized, Placebo-Controlled, Multicenter Trial

(2020) Sophie Dupuis-Girod et al.   Journal of Clinical Medicine

Trauma Can Induce Telangiectases in Hereditary Hemorrhagic Telangiectasia

(2020) Urban Geisthoff et al.   Journal of Clinical Medicine

Review of Pharmacological Strategies with Repurposed Drugs for Hereditary Hemorrhagic Telangiectasia Related Bleeding

(2020) Virginia Albiñana et al.   Journal of Clinical Medicine

Oral itraconazole for epistaxis in hereditary hemorrhagic telangiectasia: a proof of concept study

(2020) S. Kroon et al.   ANGIOGENESIS

Octreotide for gastrointestinal bleeding in hereditary hemorrhagic telangiectasia: A prospective case series

(2019) Steven Kroon et al.   AMERICAN JOURNAL OF HEMATOLOGY

Quality of life in patients with hereditary haemorrhagic telangiectasia (HHT)

(2017) Roberto Zarrabeitia et al.   Health and Quality of Life Outcomes

Tacrolimus rescues the signaling and gene expression signature of endothelial ALK1 loss-of-function and improves HHT vascular pathology

(2017) Santiago Ruiz et al.   HUMAN MOLECULAR GENETICS

Insomnia and Relationship With Immunosuppressant Therapy After Lung Transplantation

(2017) Kalynn A. Rohde et al.   Progress in Transplantation

Mouse models of hereditary hemorrhagic telangiectasia: recent advances and future challenges

(2015) Simon Tual-Chalot et al.   Frontiers in Genetics

Hereditary hemorrhagic telangiectasia: genetics and molecular diagnostics in a new era

(2015) Jamie McDonald et al.   Frontiers in Genetics

Power failure: why small sample size undermines the reliability of neuroscience

(2013) Katherine S. Button et al.   NATURE REVIEWS NEUROSCIENCE

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

(2012) Sophie Dupuis-Girod et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Immunosuppressor FK506 Increases Endoglin and Activin Receptor-Like Kinase 1 Expression and Modulates Transforming Growth Factor- 1 Signaling in Endothelial Cells

(2011) V. Albinana et al.   MOLECULAR PHARMACOLOGY

The Role of Calcineurin/NFAT in SFRP2 Induced Angiogenesis—A Rationale for Breast Cancer Treatment with the Calcineurin Inhibitor Tacrolimus

(2011) Sharareh Siamakpour-Reihani et al.   PLoS One

The Impact of Tacrolimus on Vascular Endothelial Growth Factor in Experimental Corneal Neovascularization

(2010) Burak Turgut et al.   CURRENT EYE RESEARCH

An epistaxis severity score for hereditary hemorrhagic telangiectasia

(2010) Jeffrey B. Hoag et al.   LARYNGOSCOPE